[ORGANIZATION]
SYNCHRONIZE-1
Featured in 1 tracked story · first seen
Also covered in
-
Boehringer Ingelheim reports Phase III success for obesity drug survodutida
[HEALTH] · 5 sources ·
[ORGANIZATION]
Featured in 1 tracked story · first seen
[HEALTH] · 5 sources ·